Literature DB >> 20043911

The glucagon receptor antagonist BI-32169 constitutes a new class of lasso peptides.

Thomas A Knappe1, Uwe Linne, Xiulan Xie, Mohamed A Marahiel.   

Abstract

The glucagon receptor antagonist BI-32169, recently isolated from Streptomyces sp., was described as a bicyclic peptide, although its primary structure comprises conserved elements of class I and class II lasso peptides. Tandem mass spectrometric and nuclear magnetic resonance spectroscopic studies revealed that BI-32169 is a lasso-structured peptide constituting the new class III of lasso peptides. The determined lasso fold opens new avenues to improve the promising biological activity of BI-32169. Copyright 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20043911     DOI: 10.1016/j.febslet.2009.12.046

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

Review 1.  Prospecting genomes for lasso peptides.

Authors:  Mikhail O Maksimov; A James Link
Journal:  J Ind Microbiol Biotechnol       Date:  2013-10-19       Impact factor: 3.346

2.  Topoisomer differentiation of molecular knots by FTICR MS: lessons from class II lasso peptides.

Authors:  Séverine Zirah; Carlos Afonso; Uwe Linne; Thomas A Knappe; Mohamed A Marahiel; Sylvie Rebuffat; Jean-Claude Tabet
Journal:  J Am Soc Mass Spectrom       Date:  2011-02-10       Impact factor: 3.109

3.  Signatures of Mechanically Interlocked Topology of Lasso Peptides by Ion Mobility-Mass Spectrometry: Lessons from a Collection of Representatives.

Authors:  Kevin Jeanne Dit Fouque; Hélène Lavanant; Séverine Zirah; Julian D Hegemann; Marcel Zimmermann; Mohamed A Marahiel; Sylvie Rebuffat; Carlos Afonso
Journal:  J Am Soc Mass Spectrom       Date:  2016-11-03       Impact factor: 3.109

4.  Precursor-centric genome-mining approach for lasso peptide discovery.

Authors:  Mikhail O Maksimov; István Pelczer; A James Link
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

Review 5.  Bacteriocins - a viable alternative to antibiotics?

Authors:  Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Nat Rev Microbiol       Date:  2012-12-24       Impact factor: 60.633

Review 6.  The alpha-cell as target for type 2 diabetes therapy.

Authors:  Mikkel Christensen; Jonatan I Bagger; Tina Vilsbøll; Filip K Knop
Journal:  Rev Diabet Stud       Date:  2011-11-10

Review 7.  How to harness biosynthetic gene clusters of lasso peptides.

Authors:  Shinya Kodani; Kohta Unno
Journal:  J Ind Microbiol Biotechnol       Date:  2020-07-23       Impact factor: 3.346

8.  Computational design of the lasso peptide antibiotic microcin J25.

Authors:  Si Jia Pan; Wai Ling Cheung; Ho Ki Fung; Christodoulos A Floudas; A James Link
Journal:  Protein Eng Des Sel       Date:  2010-11-23       Impact factor: 1.650

9.  The antibacterial threaded-lasso peptide capistruin inhibits bacterial RNA polymerase.

Authors:  Konstantin Kuznedelov; Ekaterina Semenova; Thomas A Knappe; Damir Mukhamedyarov; Aashish Srivastava; Sujoy Chatterjee; Richard H Ebright; Mohamed A Marahiel; Konstantin Severinov
Journal:  J Mol Biol       Date:  2011-03-15       Impact factor: 5.469

10.  Structure, bioactivity, and resistance mechanism of streptomonomicin, an unusual lasso Peptide from an understudied halophilic actinomycete.

Authors:  Mikhail Metelev; Jonathan I Tietz; Joel O Melby; Patricia M Blair; Lingyang Zhu; Itamar Livnat; Konstantin Severinov; Douglas A Mitchell
Journal:  Chem Biol       Date:  2015-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.